Skip to content
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

NO LETUP IN SURGE OF VAX BIZ REVENUES

Keeping up with the Delta variant, or any other variants of COVID-19 as may appear, via booster shots for existing vaccines or new vaccines targeting new variants, may drive Pfizer’s vaccines sales for this year to $43.5 billion, $1.5 billion more than the company’s total revenue last year.
And all the various reports in this Trends Journal about vaccines losing effectiveness over time, or allowing “breakthrough” infections (COVID infections in persons already fully vaccinated), rather than hurt the company, tend to ensure that more and more doses will be produced and purchased.
On 20 April, in “PFIZER CEO: THIRD TIME IS A CHARM,” we reported that Albert Bourla had declared that, despite the original hype that two shots of the company’s vaccine would confer immunity, booster shots would likely be needed and even evolve into an annual need, “like seasonal flu shots.” And that projection was shared by other Drug Lords, such as Johnson & Johnson CEO Alex Gorsky.
We also reported that Pfizer looked upon the world’s continued need for COVID vaccines as a “durable revenue stream.” 
TRENDPOST: For anyone to look askance at the policy of “all vaccines, all the time,” to draw attention to the fact that no COVID vaccine yet has complete approval by the FDA, or to bring up the serious side effects that have accompanied vaccinations, opens one up to charges of spreading “misinformation” and of being a wild-eyed, irrational conspiracy theorist. Again, as we have detailed in this and other Trends Journals, as with previous wars, only the side supporting it is permitted in the mainstream media.
We reported that according to studies conducted by Fairness and Accuracy in Reporting (FAIR), 64 percent of the sources mainstream media used to cover the Iraq War were pro-war, while total anti-war sources made up only 10 percent of the media’s reporting, of which only 3 percent of U.S. sources were anti-war.
FAIR also found that current or former government and military officials accounted for 76 percent of all 319 sources for news stories aired on network news channels about Iraq. And according to FAIR, for two weeks following Secretary of State Colin Powell’s error-filled speech to the United Nations in which he made bogus WMD claims for war against Iraq, U.S. TV networks banished contrary perspectives. Of the 393 on-camera sources appearing on ABC, CBS, NBC and PBS newscasts, only one percent were anti-war and just 6 percent were skeptical sources.
Again, COVID War, Vaccine War, Iraq War… those supporting Freedom, Peace and Justice are banned from the warmongering media. 

Comments are closed.